Investor Presentation

BANKA BIOLOO LIMITED R egistered Office: A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004 Corporate Office: 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016 +91 8688825013 • info@bankabio.com • www.bankabio.com • CIN: L90001TG2012PLC082811 An ISO 9001-2015-14001-2015-45001-2018 Company BBL/ SECT/23/2026-27 Date: 13 August 2026 The Listing Department, National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai- 400 051 NSE Symbol: BANKA Sub: Investor Presentation on the financial results for the quarter year ended 30 June 2026 Dear Sir/Madam, Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the investor presentation on the financial results for the quarter ended 30 June 2026. We request you to kindly take note of the same in your record. Thank you, For Banka BioLoo Limited Vishal Murarka CEO & Executive Director Encl: As above Investor Presentation Quarter 1, FY 2026–27 Safe Harbour: This presentation contains forward-looking statements subject to risks and uncertainties; actual results may differ materially. It does not constitute an offer or invitation to purchase securities. BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Safe Harbour Disclaimer —forward-looking statements and permitted use of this presentation • This presentation and the accompanying slides (the “Presentation”), prepared by Banka Bioloo Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis of or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except bymeans of a statutory offering document containing detailed information about the Company. • This Presentation has been prepared based on information and data which the Company considers reliable, but the Company makes no representation or warranty,express orimplied, and no reliance shall be placed on the truth, accuracy,completeness, fairness and reasonableness of its contents. • This Presentation may not be all-inclusive and may not contain all information you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. It contains certain forward-looking statements concerning the Company’s future business prospects and profitability, which are subject to several risks and uncertainties; actual results could materially differ. These risks include, but are not limited to, fluctuations in earnings, ability to manage growth, competition (domestic and international), economic growth in India and abroad, ability to attract and retain skilled professionals, time and cost overruns on contracts, management of international operations, government policies, regulations, and interest and fiscal costs prevailing in the economy. • The Company does not undertake to announce, in case any of these forward-looking statements become materially incorrect in future, or to update any forward-looking statements made from timeto timebyor on behalf of the Company. BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation The Wastewater & Sanitation Crisis The opportunity —scale of the sanitation and water-reuse gap Banka Bioloo addresses Untreated wastewater The majority of sewage in fast-urbanising cities is discharged without treatment, polluting rivers and groundwater. 3 Billion people worldwide face inadequate sanitation and declining Sanitation deficit water quality. Millions still lack access to safe, dignified toilets —an acute burden on marginalised communities. A $Bn market gap Water stress & reuse gap Freshwater scarcity is rising yet recycle-and-reuse infrastructure remains under-built across urban India. BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Impact at a Glance Scale and reach across sanitation, water treatment and railway operations 25,000+ 25,000+ >12 MLD Bio-toilet units deployed Railways systems serviced daily Faecal sludge treated >4 BLD 650+ 7 zones · 26 states Used water treated Employees on roll Pan-India presence Our impact. We address socio-economic inequalities and improve quality of life for marginalised communities through safe sanitation, water reuse and dignified livelihoods. BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Partial Client List Trusted by railways, government bodies, Grade-A developers and industrial clients across India BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Business Overview Banka BioLoo Limited delivers innovation in water, sanitation and hygiene (WaSH) through two focused business lines. Banka Rail Banka WaSH • AMOC —bio-toilet operations & maintenance • EPC in urban water & wastewater • POH —periodic overhauling & bogie upgradation • O&M / BOOT for recycle & reuse projects ( • QWS —quick watering systems • Bio-digesters (DRDO partnership) • Coach upgradation & passenger amenity works • Faecal Septage Treatment Plants (FSTP) 40+ projects under operation | >12 MLD fecal sludge treated | >4+ Billion sewage Multiple Railway zones | 25,000+ systems serviced daily treated annually (under BOOT projects) Figures shown are as last reported for Q1 FY25-26 —confirm and update if changed for Q1 FY26-27. Delivered through: EPC O&M BOOT HAM Key Audiences: Residential and Retail Government and Railways Industries and Corporates BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Order Book & Outlook Order booking and unexecuted order book by segment —Q1 FY26-27 actual (₹ Cr) Order Book — Q1 FY26-27 Actual (₹ Cr) Notable Wins 82 • Won an order with Auro Infra -Hyderabad • We expanded into Bangalore and Mumbai, winning projects with Brigade, Reliance and RMZ. • We secured multiple projects for our bio-toilets from construction clients and Grade-A developers in Hyderabad. Execution Outlook 32 • Revenue: Q1 FY26-27 revenue reflects a positive order conversion at the start of the year. • Order book: Q1 booking of ₹4.2 Cr against 16.2 Cr executed leaves an unexecuted book of ₹82 Cr —multi-quarter visibility to rebuild revenue through FY26-27. Rail WaSH Total Q1 Order Booking Unexecuted Order Book (YTD) BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Financial Performance Quarter 1, FY 2026–27 — Standalone, figures in ₹ Lakhs unless noted Revenue, EBITDA & PAT —Q1 FY25-26 vs Q1 FY26-27 (₹ Lakhs) Revenue (left axis) EBITDA (right axis) PAT (right axis) 2,000 1,800 1,640 160 1,600 140 1,361 1,400 120 1,200 103 1,000 600 37 400 14 200 20 Q1 FY25-26 Q1 FY26-27 REVENUE EBITDA PAT 1640 151 37 ₹ L ₹ L ₹ L 20.5%+ YoY vs 1,361 L 46.6%+ YoY vs 103 L 162.3%+ YoY vs 14 L Summary: [One-line takeaway on Q1 FY26-27 performance vs Q1 FY25-26 —fill in once actuals are available.] BANKA BIOLOO LIMITED | Q1 FY26-27 Investor Presentation Strictly Private & Confidential —Not for Circulation Megaliter Varunaa: Scaling a Long-Term Water Infrastructure Portfolio Portfolio has compounded rapidly across projects, treatment capacity and long-term contracted value Megaliter Growth —Cumulative Plants, Treatment Capacity & Net LTV (2022–2026) Cum. Plant (nos.) Cum. Treatment Capacity (MLD) Cum. Net LTV (₹ Cr) 16 15 140 122.1 11.7 8 49.4 6 60 6 5.3 4 20.2 4 3 12.9 5.2 20 2022-23 2023-24 2024-23 2025-26 YTD 2026-27 PROJECTS ONBOARDED TREATMENT CAPACITY NET LTV 15 (+1 LOI stage) 11.7 ₹122 MLD Cr From the first 600 KLD project in mid-20 [Showing first 8,000 characters — download PDF for full document]